Pharmacotherapy Secrets in Iron Deficiency Anemia
For clinicians and pharmacists, managing iron deficiency anemia (IDA) effectively requires a shift from simply replacing iron to a strategic, physiology-based approach.
Anemia is defined as hemoglobin (Hb) <12 g/dL in menstruating women, <11 g/dL in pregnancy, and <13 g/dL in men. The most critical "secret" in management is that IDA in men and postmenopausal women is an occult gastrointestinal bleed until proven otherwise, requiring urgent investigation.
- While serum ferritin is the most specific marker of storage, it is an acute-phase reactant; in patients with chronic inflammation, normal ferritin of up to 100 mcg/L (or even higher in CKD) can still coexist with absolute deficiency.
- When ferritin is inconclusive, look at Transferrin Saturation (TSAT); TSAT <16-20% indicates that the iron supply to the bone marrow is inadequate.
The old-school "three times a day" dosing of ferrous sulfate is now considered counterproductive because iron ingestion triggers a rise in hepcidin (hormone that blocks further iron absorption for up to 48 hours). A key advanced protocol is alternate-day dosing (e.g., Monday, Wednesday, Friday), which provides nearly equivalent total absorption with significantly fewer gastrointestinal side effects. For most patients, 40-60 mg of elemental iron daily or 80-100 mg on alternate days is sufficient. Clinicians should avoid enteric-coated or sustained-release preparations, as these often release iron too far past the duodenum, the primary site of absorption.
Iron is best absorbed in its ferrous (Fe2+) state within a mildly acidic medium. Patients should be counseled to avoid tea, coffee, calcium supplements, dairy, and eggs for at least 2 hours around their dose, as these items contain inhibitors like tannates and phytates that bind iron. While often overstated, taking iron with 250-500 mg of Vitamin C or a glass of orange juice may slightly enhance fractional absorption. If tablets are poorly tolerated, switching to a liquid iron formulation allows for precise dose titration to find the patient's individual tolerance threshold.
IV iron should not be reserved as a "last resort" but used early when oral iron is likely to fail. Key indications include oral intolerance, severe anemia (Hb <7-8 g/dL), clinically active IBD, gastric bypass surgery, and the second or third trimester of pregnancy.
- Ferric carboxymaltose (FCM) is a popular rapid-infusion agent, but it carries a specific secret hazard: symptomatic hypophosphatemia, which can lead to osteomalacia and fractures.
- Do not use routine antihistamines (like diphenhydramine) as premedication. Most IV iron reactions are rate-related "Fishbane reactions" (flushing/myalgias) rather than true allergies; Benadryl can cause hypotension and tachycardia, making a minor reaction look like life-threatening anaphylaxis.
- Low molecular weight (LMW) iron dextran is highly cost-effective and can be safely given as a 1000 mg total dose infusion over one hour. Ferric derisomaltose and Ferumoxytol are also excellent single-dose options without the unique phosphate risk of FCM.
If the Hb hasn't risen by at least 1 g/dL after 2-3 weeks of treatment, the case must be re-evaluated. Beyond non-adherence, clinicians should screen for hidden "blocks" to absorption, specifically Celiac disease, Helicobacter pylori infection, or autoimmune gastritis. Finally, remember that repletion is a marathon; treatment should generally continue for 3-6 months after the Hb normalizes to ensure the body's storage tanks (ferritin) are actually full.
References
- Auerbach M, et al. Treatment of iron deficiency and iron deficiency anemia in adults. UpToDate. Available from: https://www.uptodate.com/contents/treatment-of-iron-deficiency-and-iron-deficiency-anemia-in-adults.
- Aisenberg GM, Carney BJ, Aird W, Fedorowicz Z. Iron deficiency anemia in adults. DynaMedex. Updated June 22, 2026.
